One of the pillars of Iran's pharmaceutical industry with a history of nearly half a century of continuous activity
The largest manufacturer of cardiovascular drugs in the country
The first manufacturer of ready-to-inject enoxaparin sodium syringes with the Enoxan brand in Iran
Advanced PFS production system and extensive export network
۱۵۳ types of manufactured drugs
Has the largest and most equipped multi-storey warehouse in Iran
GMP certified for all lines
Received a silver statuette in the ۷th Excellence and Progress Award
History
Alborz Darou Pharmaceutical Company, one of the cornerstones of Iran’s pharmaceutical industry, with nearly half a century of continuous operation, is currently recognized as the country’s largest producer of cardiovascular medications.
Our journey began in 1976. After operating under various titles over the years, the company was officially established as “Alborz Darou” in 1984.
Throughout the decades, by advancing our technologies, improving infrastructure, and scaling up production capacity, Alborz Darou has played a pivotal role in supplying vital medications to the country.
Being ranked among the top five public pharmaceutical companies is the result of these years of dedication and an unwavering commitment to quality.
Management Statement
International Cooperation
Expanding partnerships with foreign companies for technology transfer and improving product quality.
Development of Export Markets
Active presence in regional and global markets and increasing the share of exports.
Focus on Profitable Products
Increase the share of high value-added products to improve financial efficiency.
Expanding the Product Portfolio
Adding new products based on emerging pharmaceutical market needs.
Enhancing GMP Standards
Improving infrastructure and processes to fully comply with international GMP requirements.
Strengthening Relationships with Stakeholders
Increasing effective interactions with employees, business partners, and regulatory authorities.
Guiding Principles of Alborz Darou Company
To create value for key stakeholders and contribute to sustainable development by promoting public health through the supply and development of high-quality human pharmaceutical products, formulations, and raw materials, while leveraging human capital and knowledge-based technologies in domestic and international markets
Export
Over the past decade, Alborz Darou has established a significant international presence by exporting high-quality, competitive pharmaceutical products to a diverse range of markets, including Iraq, Syria, Pakistan, Afghanistan, Uganda, Belarus, Tajikistan, and Lebanon.
